
Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease
Keywords: Hepatic fibrosis; Cholestatic liver fibrosis; Hepatic stellate cell; Anti-fibrotic treatment; TGF-β pathway; Cthrc1; collagen triple helix repeat containing-1; TGF-β; transforming growth factor-β; CBDL; common bile duct ligation; DDC; 3, 5-diethoxycarb